Table 2 Patient discharge medication.

From: Resting heart rate assessed within clinical practice demonstrates no prognostic relevance for defibrillator recipients in the German DEVICE registry

 

≤ 70 bpm (n = 856)

> 70 bpm (n = 733)

p

OR (95% CI)

ACE-I/Sartane

83.1 (707/851)

86.7 (633/730)

0.045

0.75 (0.57–0.99)

Betablocker

90.5 (770/851)

90.3 (659/730)

0.89

Aldosterone antagonist

37.4 (318/851)

36.7 (268/730)

0.79

Diuretics

63.8 (543/851)

70.5 (515/730)

0.005

0.74 (0.60–0.91)

Digitalis

10.8 (92/850)

10.4 (76/730)

0.79

Class I anti-arrhythmic drugs

0.9 (8/850)

0.4 (3/730)

0.21

Class III anti-arrhythmic drugs

11.1 (94/849)

10.1 (74/730)

0.55

 Amiodaron

95.7 (90/94)

95.9 (71/74)

0.44

 Sotalol

3.2 (3/94)

1.4 (1/74)

0.95

Class IV anti-arrhythmic drugs

4.7 (40/850)

4.2 (31/730)

0.66

Oral anticoagulation

22.8 (92/404)

23.2 (82/354)

0.90

Statin

56.5 (481/851)

59.0 (431/730)

0.31

  1. Parameters are shown as % (n).
  2. ACE-I angiotensin converting enzyme-inhibitor, CI confidence interval, OR odds ratio.